XTL BIOPHARMACEUTICALS LTD

Ticker: XTLB CUSIP: 98386D307 Class: COM

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 763 Value ($000) $1 Avg Close Range
Q2 2025
Shares 1,336 Value ($000) $2 Avg Close Range
Q1 2024
Shares 6,954 Value ($000) $20 Avg Close Range
Q4 2023
Shares 54 Value ($000) $0 Avg Close Range
Q3 2023
Shares 120 Value ($000) $0 Avg Close Range
Q4 2022
Shares 300 Value ($000) $0 Avg Close Range
Q1 2022
Shares 812 Value ($000) $2 Avg Close Range
Q4 2021
Shares 154 Value ($000) $0 Avg Close Range
Q3 2021
Shares 2,898 Value ($000) $13 Avg Close Range
Q1 2021
Shares 3,524 Value ($000) $12 Avg Close Range
Q3 2020
Shares 1,036 Value ($000) $2 Avg Close Range
Q4 2019
Shares 1,224 Value ($000) $2 Avg Close Range
Q3 2019
Shares 3,328 Value ($000) $5 Avg Close Range
Q2 2019
Shares 3,528 Value ($000) $7 Avg Close Range
Q1 2019
Shares 6,328 Value ($000) $15 Avg Close Range
Q4 2018
Shares 6,671 Value ($000) $12 Avg Close Range
Q3 2018
Shares 6,455 Value ($000) $14 Avg Close Range
Q2 2018
Shares 692 Value ($000) $1 Avg Close Range
Q1 2018
Shares 1,129 Value ($000) $2 Avg Close Range
Q4 2017
Shares 703 Value ($000) $2 Avg Close Range
Q3 2017
Shares 3,040 Value ($000) $7 Avg Close Range
Q2 2017
Shares 16,309 Value ($000) $52 Avg Close Range
Q1 2017
Shares 5,320 Value ($000) $14 Avg Close Range